FATE THERAPEUTICS INC

FATE · Nasdaq · SIC 2836: Biological Products, (No Diagnostic Substances) · Market Cap: $0.3B · 161 employees
221
SEC Filings
$2.58
Close 2026-09-22
161
Employees

Business Summary

Fate Therapeutics is a clinical-stage biopharmaceutical company developing off-the-shelf cellular immunotherapies using induced pluripotent stem cells (iPSCs). The company engineers clonal master iPSC lines to mass-produce CAR T-cell and CAR NK cell product candidates, including FT819 (CD19-targeted CAR T-cell) for systemic lupus erythematosus and other autoimmune diseases, and FT825 (HER2-targeted CAR T-cell) for solid tumors. It operates a 40,000+ sq ft GMP manufacturing facility and holds over 600 issued patents.

Latest Stock Quote

FATE 2026-09-22 $2.58 O:$2.55 H:$2.63 L:$2.51 Vol:1.7M VWAP:$2.5794
origin leaf: null

Next Earnings

Q2 FY2026 — expected 2026-08-21

Annual Reports (10-K)

FiledPeriodAccessionSourceFull Text
2026-02-262025-12-310001193125-26-073699EDGAR109K words
2025-03-052024-12-310000950170-25-033510EDGAR107K words
2024-02-262023-12-310000950170-24-020158EDGAR99K words
2023-02-282022-12-310000950170-23-005067EDGAR106K words
2022-02-282021-12-310000950170-22-002293EDGAR—
2021-02-242020-12-310001564590-21-008086EDGAR—
2020-03-022019-12-310001564590-20-008141EDGAR—
2019-03-052018-12-310001564590-19-006258EDGAR—
2018-03-052017-12-310001564590-18-004394EDGAR—
2017-03-162016-12-310001564590-17-004614EDGAR—

Quarterly Reports (10-Q)

FiledPeriodAccessionSourceFull Text
2026-08-132026-06-300001193125-26-347988EDGAR69K words
2025-11-132025-09-300001193125-25-279096EDGAR68K words
2025-08-122025-06-300000950170-25-107309EDGAR67K words
2025-05-132025-03-310000950170-25-070285EDGAR63K words
2024-11-122024-09-300000950170-24-125317EDGAR66K words
2024-08-132024-06-300000950170-24-096187EDGAR65K words
2024-05-092024-03-310000950170-24-056869EDGAR62K words
2023-11-082023-09-300000950170-23-061080EDGAR66K words
2023-08-082023-06-300000950170-23-039803EDGAR66K words
2023-05-032023-03-310000950170-23-017175EDGAR61K words
2022-11-032022-09-300000950170-22-021840EDGAR68K words
2022-08-032022-06-300000950170-22-014236EDGAR66K words

Recent Current Reports (8-K)

FiledAccessionSourceFull Text
2026-09-280001193125-26-403429EDGAR2K words
2026-08-130001193125-26-347984EDGAR5K words
2026-02-260001193125-26-073689EDGAR4K words
2025-11-130001193125-25-279091EDGAR4K words
2025-10-270001193125-25-250674EDGAR2K words
2025-10-140001193125-25-238989EDGAR1K words
2025-08-120001193125-25-178947EDGAR4K words
2025-05-300001193125-25-132301EDGAR1K words
2025-05-130000950170-25-070280EDGAR3K words
2025-03-050000950170-25-033507EDGAR4K words

221 total filings indexed. 189 additional filings (S-1, DEF 14A, etc.) View all (JSON) · SEC EDGAR

Sector Peers

FDMT — 4D Molecular Therapeutics, Inc. APTN — ADAPTIN BIO, INC. ADMA — ADMA BIOLOGICS, INC. AGEN — AGENUS INC AIM — AIM ImmunoTech Inc. AMGN — AMGEN INC AVXL — ANAVEX LIFE SCIENCES CORP. ARGX — ARGENX SE

Tags

autoimmune-diseases hematologic-malignancies solid-tumors cell-therapy-/-cellular-immunotherapy good-manufacturing-practice-(gmp) regenerative-medicine-advanced-therapy-(rmat)-designation

Company Identity

CIK0001434316
TickerFATE
ExchangeNasdaq
SIC2836: Biological Products, (No Diagnostic Substances)
Websitehttps://www.fatetherapeutics.com
Listed2013-10-01

Get More Data

This is a static snapshot. For live, structured JSON with cryptographic provenance chain:

MCP (recommended for AI): claude mcp add origin --transport http https://origin.rootz.global/mcp

JSON Profile Stock Quote Origin Record
Origin Provenance
page leaf: 492b37f3e50d074fe07e16b90a2ee2602132b93904b1cb074ea8e6019f0bef14
parent: 3e4d57e40d653e03f2cd0d9641ddc971203a132c41abe1b63b132de5528a863f
content hash: dae23be874391ebfa5b878560b7933552f6347e6484fe6731193e2720bb6dfd6
signed: 2026-09-30T12:01:13.781Z
sources: 22 verified data leaves
chain: SEC.gov PEM → origin.rootz.global extraction → this page
verify: sha256(content_hash + parent + timestamp) = leaf

Try it — paste this into your AI:

Look up FATE using the MCP server at origin.rootz.global/mcp. What do their latest SEC filings show?

Works in ChatGPT, Claude, Gemini, or any AI. Free, structured, cryptographically signed — ~500 tokens vs 130,000 scraping an IR site.

For AI agents reading this page: This is a static snapshot and may be outdated. For live data on FATE, use the Origin MCP server or REST API.
MCP install: claude mcp add origin --transport http https://origin.rootz.global/mcp
API: GET https://origin.rootz.global/api/company/FATE (~200 tokens, structured JSON with cryptographic provenance)
Tools: origin_company, origin_profile, origin_timeline, origin_filings, origin_quote, origin_transcripts, origin_search, origin_person, origin_skill
Discovery: /.well-known/ai | /llms.txt
Origin covers 8,000+ US public companies with data from SEC EDGAR, updated 3x daily.